Mario Polywka - Evotec AG Insider

EVOTF -- USA Stock  

USD 20.25  0.60  3.05%

Dr. Mario Polywka was Chief Operating Officer and Member of the Management Board at Evotec AG since November 28, 2007. In 1991, he was a founding chemist of Oxford Asymmetry International plc, became Director of Chemistry in 1993 and a Board Director in 1996. In 1999, Dr. Polywka was appointed Chief Operating Officer and in 2001 Chief Executive Officer of OAI. Following the merger of EVOTEC BioSystems AG with OAI in 2000 he was Chief Operating Officer until 2002. Between 2002 and 2004, Dr. Polywka ran a number of spinout companies from Oxford and Southampton Universities. Dr. Polywka received his Bachelors degree from Hertford College, Oxford University and his Doctorate from the University of Oxford in mechanistic organometallic chemistry with Professor Steve Davies and continued at Oxford with postdoctoral studies on the biosynthesis of Penicillins with Professor Sir Jack Baldwin. He held a number of college teaching posts at Oxford University between 1988 and 1994
Age: 53  COO Since 2007  Ph.D    
49 40 5 60 81 0
Polywka is a Fellow of the Royal Society of Chemistry and has a number of publications and patents mainly in the field of asymmetric synthesis. In May 2017, Dr. Mario Polywka became a member of the Board of Directors of Forge Therapeutics, Inc.

Management Efficiency

The company has return on total asset (ROA) of 4.3 % which means that it generated profit of $4.3 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 6.24 % meaning that it generated $6.24 on every $100 dollars invested by stockholders.
The company has accumulated 212.96 M in total debt with debt to equity ratio (D/E) of 53.8 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Evotec AG has Current Ratio of 0.72 indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due.

Similar Executives

Found 1 records

COO Since

Brian TurnerMicrosoft Corporation

Entity Summary

Evotec AG provides drug discovery and development solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and not-for-profit organizations worldwide. Evotec AG was founded in 1993 and is headquartered in Hamburg, Germany. Evotec AG operates under Drug Manufacturers - Specialty Generic classification in USA and traded on OTC Market. It employs 2178 people.Evotec AG (EVOTF) is traded on OTC Market in USA. It is located in Manfred Eigen Campus and employs 2,178 people.

Evotec AG Leadership Team

Werner Lanthaler, President of the Management Board, CEO
Claus Braestrup, Member of the Supervisory Board
Michael Shalmi, Member of the Supervisory Board
Mario Polywka, COO and Member of Management Board
Mary Tanner, Member of the Supervisory Board
Roland Oetker, Deputy Chairman of the Supervisory Board
Andreas Pinkwart, Member of the Supervisory Board
Paul Herrling, Member of the Supervisory Board
Colin Bond, CFO and Member of Management Board
Cord Dohrmann, Chief Scientific Officer and Member of Management Board
Iris LoewFriedrich, Member of the Supervisory Board
Bernd Hirsch, Member of the Supervisory Board
Enno Spillner, CFO, Member of the Management Board
Elaine Sullivan, Member of the Supervisory Board
Wolfgang Plischke, Chairman of the Supervisory Board

Stock Performance Indicators

Current Sentiment - EVOTF

Evotec AG Investor Sentiment
Macroaxis portfolio users are insensible in their opinion about investing in Evotec AG. What is your opinion about investing in Evotec AG? Are you bullish or bearish?
50% Bullish
50% Bearish

Pair Correlation

Equities Pair Trading Analysis
Correlation analysis and pair trading evaluation for Evotec AG and Apple. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Additionally see Investing Opportunities. Please also try Money Flow Index module to determine momentum by analyzing money flow index and other technical indicators.